Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)
Status:
Completed
Trial end date:
2016-07-15
Target enrollment:
Participant gender:
Summary
This study was performed to determine the pharmacokinetic parameters of vaginal rings that
contain DHEA, testosterone, or combinations of both androgens, in comparison to the oral
administration of DHEA and the transdermal administration of testosterone.